Advanced search

Paclitaxel for malignant pleural mesothelioma: A phase II study of the EORTC Lung Cancer Cooperative Group.

(1996) BRITISH JOURNAL OF CANCER. 74(6). p.961-963
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
VANMEERBEECK, J, C DEBRUYNE, N VANZANDWIJK, PE POSTMUS, MC PENNUCCI, F VANBREUKELEN, D GALDERMANS, et al. 1996. “Paclitaxel for Malignant Pleural Mesothelioma: A Phase II Study of the EORTC Lung Cancer Cooperative Group.” British Journal of Cancer 74 (6): 961–963.
APA
VANMEERBEECK, J., DEBRUYNE, C., VANZANDWIJK, N., POSTMUS, P., PENNUCCI, M., VANBREUKELEN, F., GALDERMANS, D., et al. (1996). Paclitaxel for malignant pleural mesothelioma: A phase II study of the EORTC Lung Cancer Cooperative Group. BRITISH JOURNAL OF CANCER, 74(6), 961–963.
Vancouver
1.
VANMEERBEECK J, DEBRUYNE C, VANZANDWIJK N, POSTMUS P, PENNUCCI M, VANBREUKELEN F, et al. Paclitaxel for malignant pleural mesothelioma: A phase II study of the EORTC Lung Cancer Cooperative Group. BRITISH JOURNAL OF CANCER. 1996;74(6):961–3.
MLA
VANMEERBEECK, J, C DEBRUYNE, N VANZANDWIJK, et al. “Paclitaxel for Malignant Pleural Mesothelioma: A Phase II Study of the EORTC Lung Cancer Cooperative Group.” BRITISH JOURNAL OF CANCER 74.6 (1996): 961–963. Print.
@article{189904,
  author       = {VANMEERBEECK, J and DEBRUYNE, C and VANZANDWIJK, N and POSTMUS, PE and PENNUCCI, MC and VANBREUKELEN, F and GALDERMANS, D and GROEN, H and Pinson, Philippe and VANGLABBEKE, M and VANMARCK, E and GIACCONE, G},
  issn         = {0007-0920},
  journal      = {BRITISH JOURNAL OF CANCER},
  language     = {eng},
  number       = {6},
  pages        = {961--963},
  title        = {Paclitaxel for malignant pleural mesothelioma: A phase II study of the EORTC Lung Cancer Cooperative Group.},
  volume       = {74},
  year         = {1996},
}